They are ramping up R&D spend, moving into the cosmetic market which I think has alot of potential.
They talk against doing any share buy back, stating that it is not a good look, makes it difficult to negoiate with Insurance companies.
Recent broker coverage by Bell Potter ( who I suspect will do the CR)
The CR will be needed for R&D and possible accusition to fit penitration into the cosmetic market.
Current sp on the rise, as a CR at this level not good, suspect one at around $22 to $25
IMO DYOR
Happy to be wrong, as I do not wish for a CR, as still in the red on this one.
They are ramping up R&D spend, moving into the cosmetic market...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.72 |
Change
-0.100(0.67%) |
Mkt cap ! $737.1M | |||
| Open | High | Low | Value | Volume |
| $14.80 | $14.97 | $14.60 | $600.3K | 40.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 324 | $14.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.75 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| CUV (ASX) Chart |